Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis

Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis

Abstract Background Retinal vein occlusion (RVO) is a common retinal venous disorder that causes vision loss. No specific therapy has been developed. Controversy exists regarding two treatments: intravitreal dexamethasone implants and anti-vascular endothelial growth factor (VEGF). The goal of this...

Full description

Bibliographic Details
Main Authors: Lixiong Gao, Lijun Zhou, Chunyu Tian, Na Li, Weiyang Shao, Xiujun Peng, Qian Shi
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Ophthalmology
Subjects:
Dexamethasone intravitreal implant
Anti-VEGF treatment
Retinal vein occlusion
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12886-018-1016-7

Internet

http://link.springer.com/article/10.1186/s12886-018-1016-7

Similar Items